workshop: real world evidence - s|ngular data · pdf file1 workshop: real world evidence...
TRANSCRIPT
1
Workshop: Real World EvidenceOpportunities of Real World Data and Real World Evidence for the Pharma
Industry
2
Contents
2
456
79
Who is this course for?
Learning with real cases
Why a course on Real World Evidence?
Program
More info and contact
3
I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any purpose of comparison. If they could be obtained, they would …
show subscribers how their money was being spent, what amount of good was really being done with it, or whether the
money was doing mischief rather than good
Florence Nightingale. 1855
Workshop: Real World Evidence
4
Who is this course for?
The workshop Real World Evidence is those who want to obtain an updated learning about how to
extract useful information and knowledge from Real World Data, in order to improve business decision-making.
In particular this course is aimed at professionals of the pharma industry, in the areas of general management, finance, marketing and sales, human resources or IT that have to oversee data projects or simply have to interact with teams of data professionals.
• It is assumed that students have a
working knowledge of the vocabulary of the Bio-pharmaceutical research.
• It is NOT essential to have experience in programming and statistics.
Requirements
When and how long?
-2.5 hours
-Beginning in October 2016
Workshop: Real World Evidence
5
The seminar will provide an opportunity to review a number of case studies that will allow
attendees to clearly understand the benefits and limitations of using real-life data.
.
• You will be able to understand the different ways in which Real World Data create value for organizations in the Pharma Industry.
• You will know what Real World Data, Real World Evidence and Big Data are.• You will have a good understanding of the capabilities provided by various methods of data
analysis and to apply the most appropriate ones to provide business solutions.
At the end of the course:
Learning with real cases.
Workshop: Real World Evidence
6
Why a workshop on Real World Evidence?Austerity measures and related drug price cuts have put unprecedented pressure on the
pharmaceutical industry. Manufacturers are being asked to provide information related not only to
safety, appropriate use, and effectiveness but also clinical and economic value.
Although randomized clinical trials (RCT-Randomized Controlled Trials) remain the gold standard
of clinical tests, factors such as the heterogeneity in the response to the drug in real life, lack of
adherence to treatment, or the use of these treatments in patients different from those involved in the
process of investigation prior to the authorization, limit the generalizability of results from randomized
clinical trials.
It is necessary, therefore, data from actual clinical practice to complement the information
derived from clinical trials and report on the efficiency and safety of health interventions in real world
patients.
Workshop: Real World Evidence
7
Program
Part 1: = WhatareRealWorldData?
Part 2: = Big Data and Real World Evidence
Part 3: = LimitationsdelosRealWorldData
Parte 4: = Decision making
Parte 5: = DataSources
Parte 6: = Case studies
Parte 7: = Opportunities inPharma
Parte 8: = Firststeps
Workshop: Real World Evidence
8
MORE INFO AND CONTACT: Jose C. GonzalezCell: +1 646 403 3104
Email: [email protected]://meaningcloud.com
AltavistaBusinessCenterAvUniversidad11341º
Col.XocoDel.BenitoJuárez,03330
MEXICODF,MX
Av.delLlanoCastellano,135ºA28034Madrid
MADRID,ES54W.40thSt.
NewYork,NY10018
NEWYORK,US
9
Workshop: Real World EvidenceOpportunities of Real World Data and Real World Evidence for the Pharma
Industry